TRVI EPS Estimates
Trevi Therapeutics, Inc.
$15.31
+$0.98(+6.84%)
54
Overall
45
Value
80
Tech
39
Quality
Market Cap
$2.18B
Volume
1.41M
52W Range
$9.82 - $20.22
Target Price
$28.69
TRVI EPS estimates: the consensus estimate for Trevi Therapeutics, Inc.'s current fiscal year is -$0.48 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
TRVI EPS Estimates
- EPS estimate, current quarter
- $-0.13
- EPS estimate, next quarter
- $-0.14
- EPS estimate, current year
- $-0.48
- EPS estimate, next year
- $-0.62
- EPS growth, 3-year
- +10.74%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.32 |
| 2024 | $-0.47 |
| 2023 | $-0.29 |
| 2022 | $-0.45 |
| 2021 | $-1.49 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TRVI | $15.31 | +6.8% | 1.41M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Trevi Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW